Ingalls & Snyder LLC’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $567M | Sell |
|
|||||
|
2025
Q1 | $884M | Sell |
|
|||||
|
2024
Q4 | $408M | Sell |
|
|||||
|
2024
Q3 | $383M | Buy |
|
|||||
|
2024
Q2 | $268M | Sell |
|
|||||
|
2024
Q1 | $209M | Sell |
|
|||||
|
2023
Q4 | $271M | Buy |
|
|||||
|
2023
Q3 | $227M | Sell |
|
|||||
|
2023
Q2 | $186M | Sell |
|
|||||
|
2023
Q1 | $181M | Buy |
|
|||||
|
2022
Q4 | $139M | Sell |
|
|||||
|
2022
Q3 | $178M | Sell |
|
|||||
|
2022
Q2 | $166M | Buy |
|
|||||
|
2022
Q1 | $156M | Buy |
|
|||||
|
2021
Q4 | $133M | Sell |
|
|||||
|
2021
Q3 | $139M | Sell |
|
|||||
|
2021
Q2 | $156M | Buy |
|
|||||
|
2021
Q1 | $165M | Sell |
|
|||||
|
2020
Q4 | $191M | Sell |
|
|||||
|
2020
Q3 | $130M | Sell |
|
|||||
|
2020
Q2 | $128M | Sell |
|
|||||
|
2020
Q1 | $95.2M | Sell |
|
|||||
|
2019
Q4 | $97M | Sell |
|
|||||
|
2019
Q3 | $123M | Buy |
|
|||||
|
2019
Q2 | $95M | Buy |
|
|||||
|
2019
Q1 | $98.3M | Sell |
|
|||||
|
2018
Q4 | $112M | Sell |
|
|||||
|
2018
Q3 | $118M | Buy |
|
|||||
|
2018
Q2 | $115M | Buy |
|
|||||
|
2018
Q1 | $112M | Sell |
|
|||||
|
2017
Q4 | $125M | Buy |
|
|||||
|
2017
Q3 | $133M | Sell |
|
|||||
|
2017
Q2 | $86.3M | Sell |
|
|||||
|
2017
Q1 | $86M | Sell |
|
|||||
|
2016
Q4 | $59.2M | Sell |
|
|||||
|
2016
Q3 | $56M | Sell |
|
|||||
|
2016
Q2 | $50.1M | Buy |
|
|||||
|
2016
Q1 | $42.5M | Buy |
|
|||||
|
2015
Q4 | $44.9M | Buy |
|
|||||
|
2015
Q3 | $32.6M | Buy |
|
|||||
|
2015
Q2 | $49.3M | Buy |
|
|||||
|
2015
Q1 | $44.4M | Buy |
|
|||||
|
2014
Q4 | $21.6M | Buy |
|
|||||
|
2014
Q3 | $19.1M | Buy |
|
|||||
|
2014
Q2 | $18.6M | Buy |
|
|||||
|
2014
Q1 | $28.3M | Buy |
|
|||||
|
2013
Q4 | $17.7M | Buy |
|
|||||
|
2013
Q3 | $8.39M | Buy |
|
|||||
|
2013
Q2 | $9.07M | Buy |
|